NCT02577627View on ClinicalTrials.gov

Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC

UnknownOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

January 31, 2018

Study Completion Date

September 30, 2019

Conditions
Non-Small Cell Lung CancerSmall Cell Lung CancerProstate CancerBreast CancerColon Cancer
Interventions
DEVICE

PrediCare

Trial Locations (1)

60991

RECRUITING

Optimata Ltd., Bne ‘Atarot

Sponsors

Lead Sponsor

Optimata Ltd.
All Listed Sponsors
lead

Optimata Ltd.

INDUSTRY

NCT02577627 - Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC | Biotech Hunter | Biotech Hunter